Tag archive for ‘2017 Results’
Cryoport: Observations on 1Q, 2017 Results (CYRX, Buy, $3.05)
Investment Section Overview This report is a follow-up to my April 12, 2017 report “Cryoport: Initiating Coverage of this Highly Unique Health Care Company with a Buy (CYRX, Buy, $2.25)”. If you are unfamiliar with or need a refresher on Cryoport’s business, I would suggest that you read that report before continuing. By every measure […]